Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1
|
|
- Curtis Kerry Franklin
- 5 years ago
- Views:
Transcription
1 Clin Genet 2011: 80: Printed in Singapore. All rights reserved Short Report 2011 John Wiley & Sons A/S CLINICAL GENETICS doi: /j x Myotonia congenita and myotonic dystrophy in the same family: coexistence of a mutation and expansion in the CNBP (ZNF9 ) gene Sun C, Van Ghelue M, Tranebjærg L, Thyssen F, Nilssen Ø, Torbergsen T. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a mutation and expansion in the CNBP (ZNF9 ) gene. Clin Genet 2011: 80: John Wiley & Sons A/S, 2011 Myotonia is characterized by hyperexcitability of the muscle cell membrane. Myotonic disorders are divided into two main categories: non-dystrophic and dystrophic myotonias. The non-dystrophic myotonias involve solely the muscle system, whereas the dystrophic myotonias are characterized by multisystem involvement and additional muscle weakness. Each category is further subdivided into different groups according to additional clinical features or/and underlying genetic defects. However, the phenotypes and the pathological mechanisms of these myotonic disorders are still not entirely understood. Currently, four genes are identified to be involved in myotonia: the muscle voltage-gated sodium and chloride channel genes SCN4A and, the myotonic dystrophy protein kinase (DMPK ) gene, and the CCHC-type zinc finger, nucleic acid binding protein gene CNBP. Additional gene(s) and/or modifying factor(s) remain to be identified. In this study, we investigated a large Norwegian family with clinically different presentations of myotonic disorders. Molecular analysis revealed CCTG repeat expansions in the CNBP gene in all affected members, confirming that they have myotonic dystrophy type 2. However, a mutation c.1238c>g, causing p.phe413cys, was also identified in several affected family members. Heterozygosity for p.phe413cys seems to exaggerate the severity of myotonia and thereby, to some degree, contributing to the pronounced variability in the myotonic phenotype in this family. Conflict of interest Authors declare no conflicts of interest. CSun a,b, M Van Ghelue a,c, L Tranebjærg c,d,e, F Thyssen c, Ø Nilssen a,c and T Torbergsen f,g a Department of Clinical Medicine Medical Genetics, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway, b Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway, c Department of Medical Genetics, Division of Child and Adolescent Health, University Hospital of North Norway, Tromsø, Norway, d Department of Audiology, Bispebjerg Hospital, Copenhagen, Denmark, e Wilhelm Johannsen Centre of Functional Genomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark, f Department of Neurology, University Hospital of North Norway, Tromsø, Norway, and g Department of Neurology, National University Hospital, Oslo, Norway Key words: mutation CNBP tetranucleotide repeat expansion myotonic dystrophy type 2 (DM2) myotonia congenita Corresponding author: Chen Sun, MD, Department of Obstetrics and Gynecology, Haukeland University Hospital, N-5021 Bergen, Norway. Tel.: ; fax: ; chen.sun@helse-bergen.no Received 18 August 2010, revised and accepted for publication 13 December
2 Myotonia congenita and myotonic dystrophy in the same family There are two main categories of myotonic disorders: non-dystrophic and dystrophic myotonias. Non-dystrophic myotonias are caused by mutations in genes and SCN4A which encode the voltage-gated skeletal muscle chloride channel (ClC-1) and the α-subunit of the voltage-gated skeletal muscle sodium channel (SCN4), respectively (1, 2, 3). These non-dystrophic myotonic disorders involve solely the muscle system. Myotonic dystrophy (DM) is classified into type 1 (DM1) and type 2 [DM2/proximal myotonic dystrophy (PDM)/proximal myotonic myopathy (PROMM)] (4 6). DM1 is caused by a (CTG) n expansion in the 3 -untranslated region of the dystrophia myotonica protein kinase gene, DMPK (7). DM2 is caused by a (CCTG) n expansion in intron 1 of the CCHC-type zinc finger protein gene, CNBP, previously called ZNF9 (8, 9). Both are multisystemic disorders characterized by myotonia, muscle weakness and wasting, cataracts, and other system involvements including the heart and the central nervous system (4, 5). DM2 differs from DM1 by a predominant proximal muscle weakness and atrophy at onset, doubtful congenital form and anticipation. Both DMs are thought to be RNA-mediated diseases caused by a dominant negative effect on the expression of other genes (10, 11), including (12 14). The myotonic disorders are clinically highly heterogeneous with considerable high inter- and intra-generational variations within and between affected families. In this study, we present the clinical and molecular findings in a Norwegian family presenting with the clinical coexistence of dystrophic and non-dystrophic myotonias. Expansions of the CNBP gene were identified in all affected family members. In addition, a mutation causing p.phe413cys was also detected in several patients (15). We investigated if heterozygosity for p.phe413cys has a modifying effect on the DM2 phenotype and thereby causing the unusual myotonic phenotype in this family. Materials and methods Patient ascertainment The family pedigree is shown in Fig. 1. Informed consent was obtained and the study was approved by the Regional Committee for Medical Research Ethics. I:1 I:2 II:1 II:2 II:3 II:4 II:5 II:6 EMG - EMG CNBP III:1 III:2 III:3 EMG - III:4 EMG III:5 III:6 III:7 III:8 III:9 III:10 III:11 CNBP IV:1 IV:2 IV:3 IV:4 IV:5 EMG - CNBP Fig. 1. Pedigree of the investigated family. Individuals with positive electrical myotonia on EMG are defined as affected. Family members who had clinical and EMG examinations are indicated with EMG /+. Results from the molecular analysis of the and CNBP genes are depicted beneath each investigated individual. The presence or absence of c.1238c>g resulting in p.phe413cys in the gene is indicated as p.phe413cys and, respectively. Note that not all affected family members are heterozygous carriers of the p.phe413cys mutation. Non-expanded CNBP alleles are depicted by whereas abnormally expanded alleles are denoted by exp. Expanded alleles (exp) range is size from 10 to 15 kb except for patient III:11 who displayed a repeatsize-expansion of approximately 3 4 kb. It should be noted, however, that repeat-sizes in the pathogenic range does not correlate with disease severity. 575
3 Sun et al. A neurologic examination was performed, including tests for active and percussion myotonia and for muscle weakness. Electromyography (EMG) was performed by concentric needle electrode using Keypoint EMG equipment (Medtronic Copenhagen, Denmark). The extensor digitorum communis and the anterior tibial muscles were examined. Myotonic discharges were recorded and the motor unit potentials were analyzed for low amplitude, short durations and early recruitment. All examinations were performed by one neurologist (T. T.). Individuals were classified as affected if myotonic runs were present on EMG. The clinical and EMG myotonia were further classified in four categories (+/, +, ++, and+++) depending on the degree of affection (suspected, mild, moderate, and pronounced). Blood samples were investigated for the creatine kinase (CK), gamma-glutamyl transpeptidase (γ- GT), aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT) and lactate dehydrogenase (LD). Muscle biopsy, ECG (electrocardiography), and cerebral computed tomography (CT) scan were performed occasionally. Genotyping and sequencing analysis Genomic DNA was extracted from peripheral blood cells using an automated DNA extractor (Genepure 341 Nucleic Acid Purification System, Applied Biosystems Inc., Foster City, CA, USA). Haplotype analysis of the gene was performed with chromosome 7 microsatellite markers; cen-d7s1804, D7S1824, D7S2513, and D7S661- tel, spanning a 11.3 Mb interval that harbors the gene (D7S2513 D7S661). Sequencing of the entire gene was performed in the probands. Identification of c.1238c>g in additional family members was attained as explained in Sun et al. (15). Detection of (CCTG) n repeat-sizes in the CNBP gene was done according to Liquori et al. (9), with minor modifications. A fluorescent (FAM) labeled CL3N58-D R primer was used. Polymerase chain reactions (PCRs) were cycled 30 times 94 C for 30 s, 62 C for 30 s and 72 C for 30 s. PCR products were analyzed using an ABI 3100 DNA sequencer (Applied Biosystems Inc., Foster City, CA, USA). Individuals heterozygous for alleles in the normal range ( bp) are non-carriers. Individuals with a single/homozygous allele in the normal range were subjected to Southern blot analysis performed according to Liquori et al. (9) with the following modifications: the probe was labeled using Gene Images Random Prime DNA Labeling Kit (GE Healthcare, Buckinghamshire, UK) and alleles were visualized with Gene Images CDP-Star Detection Kit (Amersham Biosystems Inc.). One patient, IV:1, was analyzed by reverse phase (RP)-PCR according to Bachinski et al. (16). Results Clinical overview The subjective symptoms and the results of clinical investigations of the patients are summarized in Table 1. Symptoms and clinical signs in the muscle system are described below. The results of various analyses and abnormalities of nonmuscle organs are mainly presented in Table S1, supporting information. The proband, II:2, has suffered from generalized myalgia during his entire adult life. He experienced attacks of central chest pain that exacerbated by cold. Cardiomyopathy was diagnosed by echocardiography. The left ventricle was greatly dilated with severely reduced function. However, instead of a restrictive filling over mitral ostium, the pattern was described to be typical for an abnormal relaxation of the myocardium. On clinical examination, he had normal cognitive function and facial expression. There was possibly marginal atrophy of the bilateral sternocleidomastoid muscles. Foot dorsiflexion, toe extension and flexion, and the Achilles reflex were mildly reduced. There was slight action myotonia. EMG showed myopathic changes and myotonic runs, consistent with DM1. Another proband, II:5 was first examined at the age of 74. He had daily myalgia and complained of weakness in both legs. Mild muscle stiffness was experienced in his hands and legs, worsening during the last years. Upon clinical examination he had normal cognitive function and facial expression. He was generally thin and distal musculature was possibly mildly atrophic. However, his muscle strength was normal. Mild percussion and action myotonia were observed. EMG showed myotonic discharges. Patient II:1 had myalgia as the only muscle symptom. His cognitive function and facial expression were normal. Clinical myotonias and muscle atrophy were absent. Shoulder abduction was possibly weakened. EMG demonstrated myotonic discharges. Patient III:2 suffered from impaired balance from age 30. She complained of increasing stiffness of her fingers and weakness in her lower extremities. Myalgia was present. Patient III:5 experienced mild muscle stiffness, general muscle weakness, and myalgia. On clinical examination, 576
4 Myotonia congenita and myotonic dystrophy in the same family Table 1. Summary of subjective muscle symptoms and clinical features of affected family members a Muscle Cases p.phe413cys/ WT =+/ Onset of myotonia Subjective symptom Stiffness Weakness Clinical myotonia EMG myotonia Subjective symptom Clinical weakness Muscle atrophy EMG myopathy Muscle pain II:1 / Adult + +/ II:2 / Adult II:5 +/ Adult III:2 / 30 years III:5 / 30 years (general) ++ +/ +/ III:6 / 22 years + b + + III:7 +/ 26 years ++ b III:9 +/ 25 years ++ b III:10 +/ 25 years +++ b (Proximal to distal) III:11 / 20 years + b IV:1 / + + IV:4 +/ +/ ++ IV:5 +/ 12 years + ++/+++ a All individuals in the table have an expansion in the CNBP gene. Some of them are also heterozygous for the mutation p.phe413cys. This table shows the variable clinical phenotypes present in this family. Both the patients subjective symptoms and clinical signs of the muscle system are summarized. As shown in the table, the result of clinical examination on muscle strength does not necessarily correspond to the subjective muscle weakness reported by the individual patient, and vice versa. Patients harboring the p.phe413cys mutation (II:5, III:7, III:9, III:10, IV:4, and IV:5) generally presented a more severe myotonia than those without. For subjective muscle stiffness and muscle pain, +++, severely affected; ++, moderately affected; +, mildly affected;, not present; EMG, electromyography. For clinical and EMG myotonia, as well as EMG myopathy, +++, pronounced; ++, moderate; +, mild; +/, suspected;, not present. For muscle weakness and muscle atrophy, +, present;, not present; +/, suspected. b Pregnancy-induced myotonia. 577
5 Sun et al. both had normal mental status and facial expression. No muscle atrophy was observed. The muscle strength of the hip flexion of III:2 was mildly reduced. So was that of the proximal part of the upper extremities of III:5. No action or percussion myotonia was found. Both showed myotonic runs and mild myopathic features on EMG. All five daughters of II:5 developed myotonia during their pregnancies (ages 20 26). After deliveries myotonia persisted. All of them had muscle stiffness in both the upper and lower limbs. Patient III:10 had the most severe myotonia with cold-induced stiffness in the perioral and periorbital muscles and occasional stiffness in the chest muscles, for example while coughing. Muscle weakness was experienced only by III:10 around her hips and in her thighs, starting during her first pregnancy. From the age of 35, she also experienced attacks of muscle weakness in her legs. Myalgia was reported by patients III:9, III:10, and III:11. Patients III:7, III:10, and III:11 also had symptoms from systems other than muscle (Table S1). Upon clinical examinations all had normal mental status and facial expressions. No muscle atrophy or hypertrophy was observed. They all showed normal muscle strength, including III:10 despite her subjective symptoms. Action and percussion myotonia were observed in all patients, to different extents (Table 1). Patient III:10 was the most severely affected with stiff movements and pronounced clinical myotonia. Myotonic discharges were present on EMG. Patient IV:1, investigated at age 26, had no symptoms from the muscle- or other systems. His mental status and facial expression were normal. However, EMG showed myotonic discharges and very mild myopathic changes. Patient IV:4 had no muscle symptoms when evaluated at age 20. However, mild action and percussion myotonia were suspected on clinical examination. EMG revealed moderate myotonic discharges. Patient IV:5 noticed muscle stiffness from age 12 with no other symptoms. Results of clinical examination at age 28 were normal. However, EMG showed pronounced myotonic discharges, whereas EMG at age 18 was normal. Their sister, IV:3, suffered from muscle stiffness in her upper and lower limbs during the last year. She experienced difficulties climbing stairs and rising from sitting position. When attempting to open a jar lid, her fingers tended to get locked. She also experienced myalgia in the lower limbs and coldinduced weakness in her hands. Her neurological examination was normal. EMG at the age of 34 showed mild myopathic features without myotonic discharges. Genetic analyses Results from the genetic analyses are displayed in Fig. 1. None of the affected family members had (CTG) n expansion in the DMPK gene (data not shown). Analysis of the CNBP gene revealed tetranucleotide expansions in all affected members. Heterozygosity for the mutation c.1238c>g, causing p.phe413cys, was detected in family members II:5, III:7, III:9, III:10, IV:3, IV:4, and IV:5. Among them, IV:3 had no EMG myotonia. Discussion In this study, we describe a large family with apparently clinically different myotonic disorders in two brothers. One of them, II:2, had bilateral cataracts, myotonia, and heart manifestation that were compatible with DM1, supported by EMG and histological findings. However, he did not have the classical facial expression. Distal muscle wasting and weakness were minimal. At the age of 64, none of the serious complications that are typical for DM1 were present. The overall clinical picture was strikingly mild. His brother II:5, at the age of 74, was clinically diagnosed with myotonia congenita (MC). The presence of DM1 and MC in a single family has been reported previously by Höweler et al. (17). Within that family DM1 and MC segregated independently. Preliminary molecular analysis of our family revealed a mutation c.1238c>g, causing p.phe413cys, previously shown to be associated with recessive MC (15). However, not all affected members carried this mutation. Haplotype analysis further excluded the, thescn4a, and the DMPK as the disease genes (data not shown). Subsequently, a CNBP (CCTG) n expansion was detected in all affected members. This family demonstrates that it may be difficult to clinically differentiate dystrophic myotonias from non-dystrophic myotonias. Recently, two separate research groups reported DM2 patients with a coexisting mutation (18, 19). Suominen et al. (19) reported that about 5% of the German and 3% of the Finnish DM2 patients carry the most frequent mutation p.arg894x, whereas, the carrier frequencies in the normal German and Finnish population were 1% and 1.3%, respectively. In addition, 2% of the Finnish DM2 population carries another frequent mutation, p.phe413cys, compared 578
6 Myotonia congenita and myotonic dystrophy in the same family to 0.7% in the normal population (19). The exact frequency of the common mutations in the DM2 population is unknown, and is not expected to be different from the normal population. Co-segregating mutations have been proposed to have an influence on the DM2 phenotype, correspondingly, the disproportional distribution of mutations among DM2 patients might reflect a selection bias towards diagnosing patients in the severe end of the phenotypic continuum (19). The family presented here might provide such an example as heterozygosity for p.phe413cys was detected in 6 of the 13 affected members. Generally, affected carriers experienced more severe muscle stiffness and showed more severe clinical and EMG myotonias than those having exclusively the CNBP expansion (Table 1). Hence, co-segregation of the mutation may modify the phenotypic effect of the CNBP expansion, contributing to a more severe phenotype. Carriers of recessive mutations are usually asymptomatic but subclinical EMG myotonia has been reported (20). Family member IV:3, who is heterozygous for p.phe413cys but harboring normal CNPB alleles, experienced muscle stiffness, cold-induced muscle weakness, and myalgia. Neither clinical, nor EMG myotonia was found; however, mild myopathic features could be recorded by EMG. It remains unknown whether heterozygosity for p.phe413cys might be involved in her mild manifestations. Cardiomyopathy is rare in DM (21), and is thought to be secondary to conduction failure and heart arrhythmias. In patient II:2 the pattern from echocardiography was suggestive for an abnormal muscle relaxation instead of a restriction filling. This indicates for the first time that the existence of myotonia in the myocardium may be the primary cause of heart manifestation in DM patients. Both dystrophic and non-dystrophic myotonias may occur during pregnancy but usually resolve after delivery (22 24). Myotonia of the five daughters of II:5 started during pregnancy, but persisted after delivery. The role of p.phe413cys in this pregnancy-induced myotonia is less clear since this mutation did not segregate with this particular trait. The mechanism underlying the pregnancyinduced myotonia is currently unknown; however, the co-incidence with pregnancy might suggest an intriguing hormonal influence. In vitro studies done by Fialho and colleagues showed that both testosterone and progesterone have an inhibitory effect on ClC-1 channels via a rapid signaling pathway (25). Lacomis et al. proposed that increased progesterone during pregnancy may affect intra- and extracellular potassium level that may enhance myotonia (23). However, as most changes during pregnancy are thought to be temporary, the effect of pregnancy at the onset and persistence of myotonia in these five sisters remains a puzzle. Further research is required to identify pregnancy-specific factors that may modify the effect of CNBP tetranucleotide expansion. Supporting Information The following Supporting information is available for this article: Table S1. Summary of non-muscle system manifestations and the results of various analyses of affected family members Additional Supporting information may be found in the online version of this article. Please note: Wiley-Blackwell Publishing is not responsible for the content or functionality of any supplementary materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article. Acknowledgements We would like to acknowledge the financial support from The Norwegian Research Council (NFR) to Chen Sun (project no /310) and from the Association for patients with Muscular Disorders to Lisbeth Tranebjærg. References 1. Ryan AM, Matthews E, Hanna MG. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias. Curr Opin Neurol 2007: 20: Bernard G, Shevell MI. Channelopathies: a review. Pediatr Neurol 2008: 38: Heatwole CR, Moxley RT 3rd. The Nondystrophic Myotonias. Neurotherapeutics 2007: 4: Day JW, Ranum LPW. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 2005: 15: Schara U, Schoser BGH. Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol 2006: 13: Cho DH, Tapscott SJ. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2007: 1772: Brook JD, McCurrach ME, Harley HG et al. Molecular basis of myotonic dystrophy: expansion of trinucleotide (CTG) repeat at the 3 end of a transcription encoding a protein kinase family member. Cell 1992: 68: Ranum LPW, Rasmussen PF, Benzow KA et al. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 1998: 19: Liquori CL, Ricker K, Moseley ML et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001: 293: Osborne RJ, Thornton CA. RNA-dominant diseases. Hum Mol Genet 2006: 15: R Wheeler TM, Thornton CA. Myotonic dystrophy: RNAmediated muscle disease. Curr Opin Neurol 2007: 20: Mankodi A, Takahashi MP, Jiang H et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel premrna and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002: 10:
7 Sun et al. 13. Charlet-B N, Savkur RS, Singh G et al. Loss of the musclespecific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002: 10: Lueck JD, Lungu C, Mankodi A et al. Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for. Am J Physiol Cell Physiol 2007: 292: C Sun C, Tranebjaerg L, Torbergsen T et al. Spectrum of mutations in patients with myotonia congenita in Northern Scandinavia. Eur J Hum Genet 2001: 9: Bachinski LL, Udd B, Meola G et al. Confirmation of the type 2 myotonic dystrophy (CCTG) n expansion in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different european origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet 2003: 73: Höweler CJ, Busch HFM, Bernini LF et al. Dystrophia myotonica and myotonia congenita concurring in one family: a clinical and genetic study. Brain 1980: 103: Lamont PJ, Jacob RL, Mastaglia FL et al. An expansion in the ZNF9 gene causes PROMM in a previously described family with an incidental mutation. J Neurol Neurosurg Psychiatry 2004: 75: Suominen T, Schoser B, Raheem O et al. High frequency of co-segregating mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol 2008: 255: Deymeer F, Lehmann-Horn F, Serdaroglu P et al. Electrical myotonia in heterozygous carriers of recessive myotonia congenita. Muscle Nerve 1999: 22: Pelargonio G, Dello Russo A, Sanna T et al. Myotonic dystrophy and the heart. Heart 2002: 88: Newman B, Meola G, O Donovan DG et al. Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy. Neuromuscular Disord 1999: 9: Lacomis D, Gonzales JT, Giuliani MJ. Fluctuating clinical myotonia and weakness from Thomsen s disease occurring only during pregnancies. Clin Neurol Neurosurg 1999: 101: Rudnik-Schöneborn S, Schneider-Gold C, Raabe U et al. Outcome and effect of pregnancy in myotonic dystrophy type 2. Neurology 2006: 66: Fialho D, Kullmann DM, Hanna MG et al. Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita. Neuromuscular Disord 2008: 18:
The expanding clinical and genetic spectrum of the myotonic dystrophies
Acta neurol. belg., 2000, 100, 151-155 Original articles The expanding clinical and genetic spectrum of the myotonic dystrophies Kenneth RICKER Department of Neurology, University of Würzburg, Germany
More informationRare Monogenic Disorders. Function. Pathophysiology
Rare Monogenic Disorders Function Pathophysiology Protein Gene Episodic Nervous System Diseases Migraine Epilepsy Periodic Paralysis LQTS Episodic Ataxia Paroxysmal Dyskinesias Phenotypes Muscle diseases
More informationClinical and genetic investigations of patients with myotonia congenita in Northern Norway
FACULTY OF HEALTH SCIENCES DEPARTMENT OF CLINICAL MEDICINE - MEDICAL GENETICS Clinical and genetic investigations of patients with myotonia congenita in Northern Norway Chen Sun A dissertation for the
More informationGenetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report
Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Roshanak Jazayeri, MD, PhD Assistant Professor of Medical Genetics Faculty of Medicine, Alborz University of Medical Sciences
More informationORIGINAL CONTRIBUTION. Laboratory Abnormalities in Patients With Myotonic Dystrophy Type 2. type 2 (DM2) is an autosomal
ORIGINAL CONTRIBUTION Laboratory Abnormalities in Patients With Myotonic Dystrophy Type 2 Chad Heatwole, MD, MS-CI; Nicholas Johnson, MD; Bradley Goldberg, BS; William Martens, BA; Richard Moxley III,
More informationRichard T. Moxley III a, *, Giovanni Meola b,1, Bjarne Udd c,1, Kenneth Ricker d,1. Workshop report
Neuromuscular Disorders 12 (2002) 306 317 Workshop report www.elsevier.com/locate/nmd Report of the 84th ENMC Workshop: PROMM (Proximal Myotonic Myopathy) and Other Myotonic Dystrophy-Like Syndromes: 2nd
More informationDifference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype
(2004) 12, 738 743 & 2004 Nature Publishing Group All rights reserved 1018-4813/04 $30.00 ARTICLE www.nature.com/ejhg Difference in allelic expression of the CLCN1 gene and the possible influence on the
More informationMyotonic Dystrophy OUTLINE
OUTLINE Myotonic Dystrophy INTRODUCTION: 1). GENERAL OVERVIEW 2). SYMPTOMS 3). DIAGNOSIS 4). CAUSES and PATHOLOGY 5). GENETICS 6). TREATMENT and MEDICAL MANAGEMENT 7). LIFESTYLE IMPACTS 8). RESEARCH 9).
More informationPrimary Periodic Paralysis. A Complex Disorder. A Challenging Diagnosis.
Primary Periodic Paralysis A Complex Disorder. A Challenging Diagnosis. A Complex Disorder A Group of Rare Channelopathies With Varying Subtypes and Triggers Primary periodic paralysis causes recurrent,
More informationClinical and genetic analysis of the first known Asian family with myotonic dystrophy type 2
OPEN (2014) 59, 129 133 & 2014 The Japan Society of Human Genetics All rights reserved 1434-5161/14 www.nature.com/jhg ORIGINAL ARTICLE Clinical and genetic analysis of the first known Asian family with
More informationEDX in Myopathies Limitations. EDX in Myopathies Utility Causes of Myopathy. Myopathy: Issues for Electromyographers
Electrodiagnostic Assessment of Myopathy Myopathy: Issues for Electromyographers Often perceived as challenging Ian Grant Division of Neurology QEII Health Sciences Centre Halifax NS CNSF EMG Course June
More informationParoxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence of a PRRT2 mutation and two CLCN1 mutations
1010 Neurosci Bull December 1, 2014, 30(6): 1010 1016. http://www.neurosci.cn DOI: 10.1007/s12264-014-1467-7 Report Paroxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence
More informationAnesthesia recommendations for patients suffering from Welander distal myopathy
orphananesthesia Anesthesia recommendations for patients suffering from Welander distal myopathy Disease name: Welander distal myopathy ICD 10: G71.0 Synonyms: late adult onset type 1 distal myopathy;
More informationSALSA MLPA KIT P060-B2 SMA
SALSA MLPA KIT P6-B2 SMA Lot 111, 511: As compared to the previous version B1 (lot 11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). Please note that, in contrast to the
More informationMuscular Dystrophy. Biol 405 Molecular Medicine
Muscular Dystrophy Biol 405 Molecular Medicine Duchenne muscular dystrophy Duchenne muscular dystrophy is a neuromuscular disease that occurs in ~ 1/3,500 male births. The disease causes developmental
More informationIndication criteria for disease: Myotonic dystrophy type 2 (DM2) [ZNF9]
deutsche gesellschaft für humangenetik e.v. Indication Criteria for Genetic Testing Evaluation of validity and clinical utility german society of human genetics www.gfhev.de Indication criteria for disease:
More informationRNA pathogenesis of the myotonic dystrophies
Neuromuscular Disorders 15 (2005) 5 16 Review RNA pathogenesis of the myotonic dystrophies John W. Day a,b, *, Laura P.W. Ranum a,c a Institute of Human Genetics, University of Minnesota, Minneapolis,
More informationDisorders of Muscle. Disorders of Muscle. Muscle Groups Involved in Myopathy. Needle Examination of EMG. History. Muscle Biopsy
Disorders of Muscle Disorders of Muscle Zakia Bell, M.D. Associate Professor of Neurology and Physical Medicine & Rehabilitation Virginia Commonwealth University Cardinal symptom of diseases of the muscle
More informationIII./10.4. Diagnosis. Introduction. A.) Laboratory tests. Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques
III./10.4. Diagnosis Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques After studying this chapter, you will become familiar with the most commonly used diagnostic
More informationMuscular Dystrophies. Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018
Muscular Dystrophies Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018 Definition and classification Clinical guide to recognize muscular
More informationHypokalaemic periodic paralysis: In these attacks the blood potassium is low
Periodic paralyses The ability we have to control and move the muscles in our body depends upon the passage of electrical signals along the nerves and into our muscles. The periodic paralyses are conditions
More informationCase 1 A 65 year old college professor came to the neurology clinic referred by her family physician because of frequent falling. She had a history of
Peripheral Nervous System Case 1 A 65 year old college professor came to the neurology clinic referred by her family physician because of frequent falling. She had a history of non-insulin dependent diabetes
More informationThe Nondystrophic Myotonias
Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics The Nondystrophic Myotonias Chad R. Heatwole* and Richard T. Moxley III* *Department of Neurology and Department
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Duchenne and Becker Muscular Dystrophy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_duchenne_and_becker_muscular_dystrophy
More informationMYOTONIA congenita (MC) is an inherited disorder
Acta Anaesthesiol Scand 2003; 47: 630 634 Copyright # Acta Anaesthesiol Scand 2003 Printed in Denmark. All rights reserved ACTA ANAESTHESIOLOGICA SCANDINAVICA ISSN 0001-5172 Anaesthetic complications associated
More informationMRC-Holland MLPA. Description version 19;
SALSA MLPA probemix P6-B2 SMA Lot B2-712, B2-312, B2-111, B2-511: As compared to the previous version B1 (lot B1-11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). SPINAL
More informationPhenotypic Variability of Autosomal Dominant Myotonia Congenita in a Taiwanese Family with Muscle Chloride Channel (CLCN1) Mutation
214 Phenotypic Variability of Autosomal Dominant Myotonia Congenita in a Taiwanese Family with Muscle Chloride Channel (CLCN1) Mutation Ting-Yu Chang 1, Hung-Chou Kuo 1, Kuang-Ming Hsiao 2, and Chin-Chang
More informationEvaluation of the Hypotonic Infant and Child
Evaluation of the Hypotonic Infant and Child Basil T. Darras, M.D. Neuromuscular Program Boston Children s Hospital Harvard Medical School Boston, MA, USA Classification and General Clinical Evaluation
More informationCase Studies in Peripheral Neurophysiology. Elliot L. Dimberg Mayo Clinic Florida 2015 American Clinical Neurophysiology Society Annual Meeting
Case Studies in Peripheral Neurophysiology Elliot L. Dimberg Mayo Clinic Florida 2015 American Clinical Neurophysiology Society Annual Meeting Disclosures None Goals and Objectives To provide a concise,
More informationORIGINAL CONTRIBUTION. Results: Unlike patients with OMD who have musculoskeletal. type 2/proximal myotonic. PROMM) is an autosomal
ORIGINAL CONTRIBUTION Musculoskeletal Pain in With Myotonic Dystrophy Type 2 Annette George, MD; Christiane Schneider-Gold, MD; Sandra Zier, MD; Karlheinz Reiners, MD; Claudia Sommer, MD Background: Myotonic
More informationNon-Mendelian inheritance
Non-Mendelian inheritance Focus on Human Disorders Peter K. Rogan, Ph.D. Laboratory of Human Molecular Genetics Children s Mercy Hospital Schools of Medicine & Computer Science and Engineering University
More informationSpinal Muscular Atrophy: Case Study. Spinal muscular atrophy (SMA) is a fairly common genetic disorder, affecting
Spinal Muscular Atrophy: Case Study Spinal muscular atrophy (SMA) is a fairly common genetic disorder, affecting approximately one in 6,000 babies. It is estimated that one in every 40 Americans carries
More informationClinical aspects, molecular pathomechanisms and management of myotonic dystrophies
Acta Myologica 2013; XXXII: p. 154-165 2013 GAETANO CONTE AWARD LECTURE Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies Giovanni Meola Department of Neurology and Laboratory
More informationLIST OF ABBREVIATIONS
PAPER 2006 Royal College of Physicians of Edinburgh Myotonic dystrophy C Longman Department of Clinical Genetics, Guy s Hospital, London, England ABSTRACT Myotonic dystrophy is the most common form of
More information140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management *
Neuromuscular Disorders 16 (2006) 403 413 www.elsevier.com/locate/nmd Workshop report 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management
More informationHomozygosity for CCTG mutation in myotonic dystrophy type 2
DOI: 10.1093/brain/awh210 Brain (2004), 127, 1868 1877 Homozygosity for CCTG mutation in myotonic dystrophy type 2 Benedikt G. H. Schoser, 1 Wolfram Kress, 2 Maggie C. Walter, 1 Birgit Halliger-Keller,
More informationNeuromuscular in the Pediatric Clinic: Recognition and Referral
Neuromuscular in the Pediatric Clinic: Recognition and Referral Matthew Harmelink, MD Assistant Professor, Pediatric Neurology Medical College of Wisconsin Objectives: 1. Understand common presentations
More informationWhat is myotonic dystrophy?
What is myotonic dystrophy? Myotonic dystrophy is a muscle condition that falls under the umbrella term muscular dystrophy. The muscular dystrophies all have three features in common; they are hereditary,
More informationGuide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists
Guide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists What is NCS/EMG? NCS examines the conduction properties of sensory and motor peripheral nerves. For both
More informationBest practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2
(2012) 20, 1203 1208 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg POLICY Best practice guidelines and recommendations on the molecular diagnosis of myotonic
More informationDiseases of Muscle and Neuromuscular Junction
Diseases of Muscle and Neuromuscular Junction Diseases of Muscle and Neuromuscular Junction Neuromuscular Junction Muscle Myastenia Gravis Eaton-Lambert Syndrome Toxic Infllammatory Denervation Atrophy
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/29354 holds various files of this Leiden University dissertation. Author: Straathof, Chiara Title: dystrophinopathies : heterogeneous clinical aspects of
More information2- and 6-minute walk tests equally well assess walking capability in neuromuscular diseases
2- and 6-minute walk tests equally well assess walking capability in neuromuscular diseases Linda Kahr Andersen, PT, MSc Copenhagen Neuromuscular Center Background The 6MWT widely used to measure treatment
More informationA novel N440K sodium channel mutation causes myotonia with exercise-induced weakness - exclusion of CLCN1 exon deletion/duplication by MLPA
Acta Myologica 2011; XXX: p. 133-137 A novel N440K sodium channel mutation causes myotonia with exercise-induced weakness - exclusion of CLCN1 exon deletion/duplication by MLPA F. Lehmann-Horn, M. Orth
More informationWhole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita
Acta Neurol Scand 2010: 121: 131 135 DOI: 10.1111/j.1600-0404.2009.01228.x Copyright Ó 2009 The Authors Journal compilation Ó 2009 Blackwell Munksgaard ACTA NEUROLOGICA SCANDINAVICA Clinical Commentary
More informationSMA IS A SEVERE NEUROLOGICAL DISORDER [1]
SMA OVERVIEW SMA IS A SEVERE NEUROLOGICAL DISORDER [1] Autosomal recessive genetic inheritance 1 in 50 people (approximately 6 million Americans) are carriers [2] 1 in 6,000 to 1 in 10,000 children born
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 January 2011
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 January 2011 MEXILETINE AP-HP 200 mg, capsule B/50 (CIP code: 559 549-8) Applicant: Etablissement Pharmaceutique
More informationClinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1
EXPERIMENTAL AND THERAPEUTIC MEDICINE 10: 1931-1936, 2015 Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1 QING LIU, YU FEI ZHENG, YAN PING ZHU, SHI QING
More informationCase Report GNE Myopathy in Turkish Sisters with a Novel Homozygous Mutation
Case Reports in Neurological Medicine Volume 2016, Article ID 8647645, 4 pages http://dx.doi.org/10.1155/2016/8647645 Case Report GNE Myopathy in Turkish Sisters with a Novel Homozygous Mutation Gulden
More informationREAD ORPHA.NET WEBSITE ABOUT BETA-SARCOGLYOCANOPATHY LIMB-GIRDLE MUSCULAR DYSTROPHIES
READ ORPHA.NET WEBSITE ABOUT BETA-SARCOGLYOCANOPATHY LIMB-GIRDLE MUSCULAR DYSTROPHIES (LGMD) Limb-girdle muscular dystrophies (LGMD) are a heterogeneous group of genetically determined disorders with a
More informationOne of the essential properties of the muscle
original paper Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies G. Meola*, V. Sansone*, G. Rotondo*, E. Mancinelli** *Istituto Policlinico San Donato,
More informationCritical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM. Andrzej Sladkowski
Critical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM Andrzej Sladkowski Potential causes of weakness in the ICU-1 Muscle disease Critical illness myopathy Inflammatory myopathy Hypokalemic
More informationAdvances in genetic diagnosis of neurological disorders
Acta Neurol Scand 2014: 129 (Suppl. 198): 20 25 DOI: 10.1111/ane.12232 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ACTA NEUROLOGICA SCANDINAVICA Review Article Advances in genetic diagnosis
More informationMRC-Holland MLPA. Description version 07; 26 November 2015
SALSA MLPA probemix P266-B1 CLCNKB Lot B1-0415, B1-0911. As compared to version A1 (lot A1-0908), one target probe for CLCNKB (exon 11) has been replaced. In addition, one reference probe has been replaced
More informationNeonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP
The floppy infant assumes a frog legged position. On ventral suspension, the baby can not maintain limb posture against gravity and assumes the position of a rag doll. Encephalopathy acute No encephalopathy
More informationTitle. CitationInternal Medicine, 46(8): Issue Date Doc URL. Type. File Information
Title Scapular Winging as a Symptom of Cervical Flexion My Author(s)Yaguchi, Hiroaki; Takahashi, Ikuko; Tashiro, Jun; Ts CitationInternal Medicine, 46(8): 511-514 Issue Date 2007-04-17 Doc URL http://hdl.handle.net/2115/20467
More informationmouse models of DM1 [23]. Approaches to restore the loss of MBNL1 function in skeletal muscle have included overexpression of MBNL1 protein via a reco
Repression of nuclear CELF activity can rescue CELFregulated alternative splicing defects in skeletal muscle models of myotonic dystrophy February 24, 2012,, Dara S. Berger, Andrea N. Ladd Berger DS, Ladd
More informationMRC-Holland MLPA. Description version 29; 31 July 2015
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082
More informationHutterite brothers both affected with two forms of limb girdle muscular dystrophy: LGMD2H and LGMD2I
(2005) 13, 978 982 & 2005 Nature Publishing Group All rights reserved 1018-4813/05 $30.00 ARTICLE www.nature.com/ejhg Hutterite brothers both with two forms of limb girdle muscular dystrophy: LGMD2H and
More informationDMD Genetics: complicated, complex and critical to understand
DMD Genetics: complicated, complex and critical to understand Stanley Nelson, MD Professor of Human Genetics, Pathology and Laboratory Medicine, and Psychiatry Co Director, Center for Duchenne Muscular
More informationO unaffected siblings. MYOTONIA CONGENITA (THOMSEN'S DISEASE) 1N A CHINESE FAMILY
Vol. 10, No. 2. SINGAPORE MEDICAL JOURNAL 111 June, 1969. MYOTONIA CONGENITA (THOMSEN'S DISEASE) 1N A CHINESE FAMILY By J. S. Cheah, M.B., B.S., M.R.A.C.P. and B. H. Toh, Ms., B.S., (Department of Medicine,
More informationAssociation of motor milestones and SMN2 copy and outcome in spinal muscular. atrophy types 0 4
jnnp-2016-314292 1 - SUPPLEMENTARY FILE - Methods and additional data on clinical characteristics and motor development Association of motor milestones and SMN2 copy and outcome in spinal muscular atrophy
More informationMuscle Channelopathies
Queen Square Centre for Neuromuscular Diseases Muscle Channelopathies Professor Michael G Hanna 25.3.17 What is a skeletal muscle channelopathy? Muscle and nerves communicate by electrical signals Electrical
More informationLearn the steps to identify pediatric muscle weakness and signs of neuromuscular disease.
Learn the steps to identify pediatric muscle weakness and signs of neuromuscular disease. Listen Observe Evaluate Test Refer Guide for primary care providers includes: Surveillance Aid: Assessing Weakness
More informationMRC-Holland MLPA. Description version 14; 28 September 2016
SALSA MLPA probemix P279-B3 CACNA1A Lot B3-0816. As compared to version B2 (lot B2-1012), one reference probe has been replaced and the length of several probes has been adjusted. Voltage-dependent calcium
More informationFunctional insights from genetic channelopathies Stephanie Schorge
Functional Insights From Genetic Channelopathies Dr. 1 Royal Society University Research Fellow Department of Clinical and Experimental Epilepsy Aims of channelopathies lecture Describe channelopathies
More informationThe Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal
The Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal Sensitization, Central Sensitization, and Allodynia
More informationvariant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still
157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can
More informationTREAT-NMD Care and Trial Sites Registry Information Chart
TREAT-NMD Care and Trial Sites Registry Information Chart Below you find a list of the information that is asked in the CTSR of all registered neuromuscular disease sites. For more information please visit
More informationGENETIC MUSCLE DISEASES: NEW INSIGHT INTO THE BASIS OF THE MYOTONIC DYSTROPHIES
GENETIC MUSCLE DISEASES: NEW INSIGHT INTO THE BASIS OF THE MYOTONIC DYSTROPHIES Bjarne Udd, Prof. of Neurology in Neuromuscular Disorders Director of the Finnish Neuromuscular Diseases Center, Tampere
More informationSupporting Online Material for
www.sciencemag.org/cgi/content/full/1171320/dc1 Supporting Online Material for A Frazzled/DCC-Dependent Transcriptional Switch Regulates Midline Axon Guidance Long Yang, David S. Garbe, Greg J. Bashaw*
More informationNational Hospital for Neurology and Neurosurgery
National Hospital for Neurology and Neurosurgery Neurophysiological testing in patients with suspected or confirmed muscle channelopathies Centre for Neuromuscular Diseases Contents 1. Introduction 2.
More informationNeonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012
Neonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012 Hypotonia: reduced tension or resistance to range of motion Localization can be central (brain), peripheral (spinal cord, nerve,
More informationAgro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17
Agro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17 INTRODUCTION - Our genes underlie every aspect of human health, both in function and
More information1/28/2019. OSF HealthCare INI Care Center Team. Neuromuscular Disease: Muscular Dystrophy. OSF HealthCare INI Care Center Team: Who are we?
Neuromuscular Disease: Muscular Dystrophy Muscular Dystrophy Association (MDA) and OSF HealthCare Illinois Neurological Institute (INI) Care Center Team The Neuromuscular clinic is a designated MDA Care
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Choroideremia OMIM number for disease 303100 Disease alternative names please
More informationSingle Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions
Single Gene (Monogenic) Disorders Mendelian Inheritance: Definitions A genetic locus is a specific position or location on a chromosome. Frequently, locus is used to refer to a specific gene. Alleles are
More informationSEX-LINKED INHERITANCE. Dr Rasime Kalkan
SEX-LINKED INHERITANCE Dr Rasime Kalkan Human Karyotype Picture of Human Chromosomes 22 Autosomes and 2 Sex Chromosomes Autosomal vs. Sex-Linked Traits can be either: Autosomal: traits (genes) are located
More informationComparison of Sudomotor and Sensory Nerve Testing in Painful Sensory Neuropathies
138 Original Article Comparison of Sudomotor and Sensory Nerve Testing in Painful Sensory Neuropathies James M. Killian, MD,* Shane Smyth, MD,* Rudy Guerra, PhD, Ishan Adhikari, MD,* and Yadollah Harati,
More informationA rare case of muscular dystrophy with POMT2 and FKRP gene mutation. Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband
A rare case of muscular dystrophy with POMT2 and FKRP gene mutation Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband Index : Congenital muscular dystrophy (CMD) Dystroglycanopathies Walker-Warburg
More informationMyotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism
Journal of Neuromuscular Diseases 2 (2015) S59 S71 DOI 10.3233/JND-150088 IOS Press Research Report S59 Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism Giovanni
More informationCold Extends Electromyography Distinction between Ion Channel Mutations Causing Myotonia
Cold Extends Electromyography Distinction between Ion Channel Mutations Causing Myotonia Emmanuel Fournier, MD, PhD, 1 5 Karine Viala, MD, 1,2 Hélène Gervais, MD, 6 Damien Sternberg, MD, PhD, 7 Marianne
More informationUnifactorial or Single Gene Disorders. Hanan Hamamy Department of Genetic Medicine and Development Geneva University Hospital
Unifactorial or Single Gene Disorders Hanan Hamamy Department of Genetic Medicine and Development Geneva University Hospital Training Course in Sexual and Reproductive Health Research Geneva 2011 Single
More informationClinical and Radiological Aspects of Myopathies
J.A.L.Bulcke A.L.Baert Clinical and Radiological Aspects of Myopathies CT Scanning EMG Radioisotopes With 151 Figures and 30 Tables Springer-Verlag Berlin Heidelberg GmbH Dr. JAN A. L BULCKE K. U. Leuven,
More informationMRC-Holland MLPA. Description version 08; 18 November 2016
SALSA MLPA probemix P122-D1 NF1 AREA Lot D1-1016. As compared to lot C2-0312, four probes in the NF1 area and one reference probe have been removed, four reference probes have been replaced and several
More informationLack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims
Kobe J. Med. Sci., Vol. 53, No. 4, pp. 151-155, 2007 Lack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims KAORU SAKURAI 1, NAOKI NISHIGUCHI 2, OSAMU SHIRAKAWA 2,
More informationPediatric Aspects of EDX
Pediatric Aspects of EDX Albert C. Clairmont, MD Associate Professor-Clinical The Ohio State University February 25, 2013 Objectives Overview of Pediatric Electrodiagnosis (EDX) Understand the different
More informationSteps in EMG analysis
Steps in EMG analysis at rest - spontaneous activity fibs, psw, myotonia, complex rep discharges fasciculations, myokymia at slight voluntary contraction - MUP shape parameters, stability (jiggle), behaviour
More informationMyotonic dystrophy (dystrophia myotonica)
ORIGINAL ARTICLE Increased Cancer Risks in Myotonic Dystrophy Aung Ko Win, MBBS, MPH; Promilla G. Perattur, MBBS; Jose S. Pulido, MD, MS, MPH, MBA; Christine M. Pulido; and Noralane M. Lindor, MD Abstract
More informationTitle Page. The skeletal muscle channelopathies: phenotype, genotype and pathogenesis. Emma Louise Matthews UCL. Submission for PhD examination
Title Page The skeletal muscle channelopathies: phenotype, genotype and pathogenesis Emma Louise Matthews UCL Submission for PhD examination Declaration I, Emma Louise Matthews confirm that the work presented
More informationBlood Types and Genetics
Blood Types and Genetics Human blood type is determined by codominant alleles. An allele is one of several different forms of genetic information that is present in our DNA at a specific location on a
More informationBasic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH
Basic Definitions Chromosomes There are two types of chromosomes: autosomes (1-22) and sex chromosomes (X & Y). Humans are composed of two groups of cells: Gametes. Ova and sperm cells, which are haploid,
More informationMRC-Holland MLPA. Description version 30; 06 June 2017
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are
More informationBenefits and pitfalls of new genetic tests
Benefits and pitfalls of new genetic tests Amanda Krause Division of Human Genetics, NHLS and University of the Witwatersrand Definition of Genetic Testing the analysis of human DNA, RNA, chromosomes,
More informationProfile, types, duration and severity of muscular dystrophy: a clinical study at a tertiary care hospital
International Journal of Advances in Medicine Viswajyothi P et al. Int J Adv Med. 2018 Jun;5(3):700-704 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20182126
More informationGaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance
Mendelian pedigree patterns Autosomal-dominant inheritance Autosomal dominant Autosomal recessive X-linked dominant X-linked recessive Y-linked Examples of AD inheritance Autosomal-recessive inheritance
More informationHoffmann s syndrome: An atypical neurological manifestation of hypothyroidism
Case report Hoffmann s syndrome: An atypical neurological manifestation of hypothyroidism Dr. Prinesh Varghese, Dr. Keni Ravish Rajiv, Dr. Uthaya Sankar Department of General Medicine, Sri Manakula Vinayagar
More informationImmunohistochemical Study of Dystrophin Associated Glycoproteins in Limb-girdle Muscular Dystrophies
Dystrophin Immunohistochemical Study of Dystrophin Associated Glycoproteins in Limb-girdle Muscular Dystrophies NSC 89-2314-B-002-111 88 8 1 89 7 31 ( Peroxidase -AntiPeroxidase Immnofluorescence) Abstract
More informationYear 2 MBChB Clinical Skills Session Examination of the Motor System
Year 2 MBChB Clinical Skills Session Examination of the Motor System Reviewed & ratified by: o o o o Dr D Smith Consultant Neurologist Dr R Davies Consultant Neurologist Dr B Michael Neurology Clinical
More informationI am pleased to provide you complimentary one-time access to my article as a PDF file for your own personal use. Any further/multiple distribution,
I am pleased to provide you complimentary one-time access to my article as a PDF file for your own personal use. Any further/multiple distribution, publication or commercial usage of this copyrighted material
More information